These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9232816)

  • 21. Strategies for reducing the renal transplant waiting list: a review.
    Shrestha BM
    Exp Clin Transplant; 2009 Sep; 7(3):173-9. PubMed ID: 19715528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].
    van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W
    Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
    Sharma A; King A; Kumar D; Behnke M; McDougan F; Kimball PM
    Prog Transplant; 2016 Jun; 26(2):157-61. PubMed ID: 27207404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kidney transplant].
    Martín P; Errasti P
    An Sist Sanit Navar; 2006; 29 Suppl 2():79-91. PubMed ID: 16998517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney Transplant Program at the Mayo Clinic in Arizona.
    Heilman RL; Khamash HA; Huskey JL; Chakkera HA; Batra RK; Katariya NN; Singer AL; Mathur AK; Moss AA; Reddy KS
    Clin Transpl; 2014; ():61-8. PubMed ID: 26281128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney transplantation at the University of Pittsburgh.
    Shapiro R; Sturdevant M; Lopez R; Tan H; Basu A; Wijkstrom M; Humar A
    Clin Transpl; 2011; ():67-76. PubMed ID: 22755403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older donors and older recipients in kidney transplantation.
    Stallone G; Infante B; Gesualdo L
    J Nephrol; 2010; 23 Suppl 15():S98-103. PubMed ID: 20872377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bridging the gap: an integrated paediatric to adult clinical service for young adults with kidney failure.
    Harden PN; Walsh G; Bandler N; Bradley S; Lonsdale D; Taylor J; Marks SD
    BMJ; 2012 Jun; 344():e3718. PubMed ID: 22661725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal immunosuppression for HIV-positive kidney transplants: long-term randomized controlled trials needed.
    Nazarian SM; Misch EA; Rakita RM; Limaye AP
    Transplantation; 2014 Jun; 97(12):e70. PubMed ID: 24933252
    [No Abstract]   [Full Text] [Related]  

  • 32. Third and fourth kidney transplant: still a reasonable option.
    Izquierdo L; Peri L; Piqueras M; Revuelta I; Alvarez-Vijande R; Musquera M; Oppenheimer F; Alcaraz A
    Transplant Proc; 2010 Sep; 42(7):2498-502. PubMed ID: 20832531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision Medicine and Personalized Approach to Renal Transplantation.
    Dafoe DC; Tantisattamo E; Reddy U
    Semin Nephrol; 2018 Jul; 38(4):346-354. PubMed ID: 30082055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.
    Gill JS; Rose C; Joffres Y; Landsberg D; Gill J
    Am J Kidney Dis; 2018 May; 71(5):636-647. PubMed ID: 29395484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive regimens and their effects on renal allograft outcome.
    Katznelson S; Cecka JM
    Clin Transpl; 1996; ():361-71. PubMed ID: 9286582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte antigen-DR mismatched pediatric renal transplant: patient and graft outcome with different kidney donor sources.
    Al-Otaibi T; Gheith O; Mosaad A; Nampoory MR; Halim M; Said T; Nair P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():117-23. PubMed ID: 25894139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection.
    Loucaidou M; McLean AG; Cairns TD; Griffith M; Hakim N; Palmer A; Papalois V; Van Tromp J; Loucaides C; Welsh KI; Taube D
    Transplantation; 2003 Oct; 76(7):1120-3. PubMed ID: 14557763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of pediatric renal transplantation: a single center study in Japan.
    Yamada A; Tashiro A; Hiraiwa T; Komatsu T; Kinukawa T; Ueda N
    Pediatr Transplant; 2014 Aug; 18(5):453-62. PubMed ID: 24931009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards graft-specific immune suppression: Gene therapy of the transplanted kidney.
    Sandovici M; Deelman LE; Benigni A; Henning RH
    Adv Drug Deliv Rev; 2010 Nov; 62(14):1358-68. PubMed ID: 20688115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.